View in EDS

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

Saved in:
Bibliographic Details
Title: The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.
Authors: Ghesquières H; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Krzisch D; Department of Hematology, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, Paris, France., Nicolas-Virelizier E; Department of Hematology, Centre Leon Berard, Claude Bernard Lyon 1 University, Lyon, France., Kanoun S; Department of Hematology, Cancer Research Center of Toulouse, Team 9, INSERM Unité Mixte de Recherche 1037, Toulouse, France., Gac AC; Department of Hematology, Institut d'Hematologie de Basse Normandie, Caen, France., Guidez S; Hematology Department, Centre Hospitalier Universitaire, Poitiers, France., Touati M; Department of Hematology, Hôpital Dupuytren, Centre Hospitalier Universitaire, Limoges, France., Laribi K; Hematology Department, Centre Hospitalier, Le Mans, France., Morschhauser F; Department of Hematology, Centre Hospitalier Universitaire Lille, Universite de Lille, ULR 7365 Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Bonnet C; Department of Hematology, University Hospital Liege, Liege, Belgium., Waultier-Rascalou A; Hematology of Department, Centre Hospitalier Universitaire, Nimes, France., Orsini-Piocelle F; Department of Hematology, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France., André M; Department of Hematology, Centre Hospitalier Universitaire, Université Catholique de Louvain Namur, Université Catholique de Louvain, Yvoir, Belgium., Fournier M; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Morand F; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France., Berriolo-Riedinger A; Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France., Burroni B; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Damotte D; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France., Traverse-Glehen A; Department of Pathology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France., Quittet P; Department of Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France., Casasnovas O; Department of Hematology, University Hospital F. Mitterrand and INSERM Unité Mixte de Recherche 1231, Dijon, France.
Source: Blood [Blood] 2024 Mar 14; Vol. 143 (11), pp. 983-995.
Publication Type: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37979133
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ghesquières+H%22">Ghesquières H</searchLink>; Department of Hematology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France.<br /><searchLink fieldCode="AU" term="%22Krzisch+D%22">Krzisch D</searchLink>; Department of Hematology, Assistance Publique Hopitaux de Paris, Hopital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nicolas-Virelizier+E%22">Nicolas-Virelizier E</searchLink>; Department of Hematology, Centre Leon Berard, Claude Bernard Lyon 1 University, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Kanoun+S%22">Kanoun S</searchLink>; Department of Hematology, Cancer Research Center of Toulouse, Team 9, INSERM Unité Mixte de Recherche 1037, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gac+AC%22">Gac AC</searchLink>; Department of Hematology, Institut d'Hematologie de Basse Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Guidez+S%22">Guidez S</searchLink>; Hematology Department, Centre Hospitalier Universitaire, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Touati+M%22">Touati M</searchLink>; Department of Hematology, Hôpital Dupuytren, Centre Hospitalier Universitaire, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Laribi+K%22">Laribi K</searchLink>; Hematology Department, Centre Hospitalier, Le Mans, France.<br /><searchLink fieldCode="AU" term="%22Morschhauser+F%22">Morschhauser F</searchLink>; Department of Hematology, Centre Hospitalier Universitaire Lille, Universite de Lille, ULR 7365 Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.<br /><searchLink fieldCode="AU" term="%22Bonnet+C%22">Bonnet C</searchLink>; Department of Hematology, University Hospital Liege, Liege, Belgium.<br /><searchLink fieldCode="AU" term="%22Waultier-Rascalou+A%22">Waultier-Rascalou A</searchLink>; Hematology of Department, Centre Hospitalier Universitaire, Nimes, France.<br /><searchLink fieldCode="AU" term="%22Orsini-Piocelle+F%22">Orsini-Piocelle F</searchLink>; Department of Hematology, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France.<br /><searchLink fieldCode="AU" term="%22André+M%22">André M</searchLink>; Department of Hematology, Centre Hospitalier Universitaire, Université Catholique de Louvain Namur, Université Catholique de Louvain, Yvoir, Belgium.<br /><searchLink fieldCode="AU" term="%22Fournier+M%22">Fournier M</searchLink>; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France.<br /><searchLink fieldCode="AU" term="%22Morand+F%22">Morand F</searchLink>; Department of Statistics, Lymphoma Study Association Clinical Research, Hopital Lyon Sud, Pierre Benite, France.<br /><searchLink fieldCode="AU" term="%22Berriolo-Riedinger+A%22">Berriolo-Riedinger A</searchLink>; Department of Nuclear Medicine, Centre GF Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Burroni+B%22">Burroni B</searchLink>; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Damotte+D%22">Damotte D</searchLink>; Department of Pathology, Université de Paris Cité, Centre de Recherche des Cordeliers UMRS U1138 et GH Paris Centre APHP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Traverse-Glehen+A%22">Traverse-Glehen A</searchLink>; Department of Pathology, Hopital Lyon Sud, Claude Bernard Lyon 1 University, Pierre Benite, France.<br /><searchLink fieldCode="AU" term="%22Quittet+P%22">Quittet P</searchLink>; Department of Hematology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+O%22">Casasnovas O</searchLink>; Department of Hematology, University Hospital F. Mitterrand and INSERM Unité Mixte de Recherche 1231, Dijon, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2024 Mar 14; Vol. 143 (11), pp. 983-995.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37979133
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2023021564
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 983
    Titles:
      – TitleFull: The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ghesquières H
      – PersonEntity:
          Name:
            NameFull: Krzisch D
      – PersonEntity:
          Name:
            NameFull: Nicolas-Virelizier E
      – PersonEntity:
          Name:
            NameFull: Kanoun S
      – PersonEntity:
          Name:
            NameFull: Gac AC
      – PersonEntity:
          Name:
            NameFull: Guidez S
      – PersonEntity:
          Name:
            NameFull: Touati M
      – PersonEntity:
          Name:
            NameFull: Laribi K
      – PersonEntity:
          Name:
            NameFull: Morschhauser F
      – PersonEntity:
          Name:
            NameFull: Bonnet C
      – PersonEntity:
          Name:
            NameFull: Waultier-Rascalou A
      – PersonEntity:
          Name:
            NameFull: Orsini-Piocelle F
      – PersonEntity:
          Name:
            NameFull: André M
      – PersonEntity:
          Name:
            NameFull: Fournier M
      – PersonEntity:
          Name:
            NameFull: Morand F
      – PersonEntity:
          Name:
            NameFull: Berriolo-Riedinger A
      – PersonEntity:
          Name:
            NameFull: Burroni B
      – PersonEntity:
          Name:
            NameFull: Damotte D
      – PersonEntity:
          Name:
            NameFull: Traverse-Glehen A
      – PersonEntity:
          Name:
            NameFull: Quittet P
      – PersonEntity:
          Name:
            NameFull: Casasnovas O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 03
              Text: 2024 Mar 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 143
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1